Terms: = Thyroid cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV
4 results:
1. I-PET score: Combining whole body iodine and
Wijewardene A; Hoang J; Maw AM; Gild M; Tacon L; Roach P; Schembri G; Chan D; Clifton-Bligh R
Clin Endocrinol (Oxf); 2023 Mar; 98(3):436-446. PubMed ID: 35918798
[TBL] [Abstract] [Full Text] [Related]
2. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.
Bodet-Milin C; Faivre-Chauvet A; Carlier T; Ansquer C; Rauscher A; Frampas E; Toulgoat F; Masson D; Bourgeois M; Cerato E; Rohmer V; Couturier O; Drui D; Goldenberg DM; Sharkey RM; Barbet J; Kraeber-Bodere F
J Nucl Med; 2021 Sep; 62(9):1221-1227. PubMed ID: 33547213
[TBL] [Abstract] [Full Text] [Related]
3. Predictors of long-term compensatory response of pulmonary function following major lung resection for non-small cell lung cancer.
Takahashi Y; Matsutani N; Morita S; Dejima H; Nakayama T; Uehara H; Kawamura M
Respirology; 2017 Feb; 22(2):364-371. PubMed ID: 27649690
[TBL] [Abstract] [Full Text] [Related]
4. Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
Kim WG; Ryu JS; Kim EY; Lee JH; Baek JH; Yoon JH; Hong SJ; Kim ES; Kim TY; Kim WB; Shong YK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1169-73. PubMed ID: 20080852
[TBL] [Abstract] [Full Text] [Related]
